$BBAI
BigBear.ai Holdings Inc Stock $bbai

$bbai Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000162828022014091 Filed on May 12, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$36.39M	$145.6M	$35.57M
YoY Change	2.31%
Cost Of Revenue	$26.52M	$111.5M	$25.29M
YoY Change	4.88%
Gross Profit	$9.867M	$34.07M	$10.28M
YoY Change	-4.02%
Gross Profit Margin	27.11%	23.4%	28.9%
Selling, General & Admin	$22.02M	$102.4M	$10.11M
YoY Change	117.72%
% of Gross Profit	223.17%	300.6%	98.39%
Research & Development	$2.874M	$6.033M	$928.0K
YoY Change	209.7%
% of Gross Profit	29.13%	17.71%	9.03%
Depreciation & Amortization	$1.772M	$7.262M
YoY Change
% of Gross Profit	17.96%	21.32%
Operating Expenses	$24.89M	$108.4M	$11.04M
YoY Change	125.45%
Operating Profit	-$16.43M	-$74.37M	-$762.0K
YoY Change	2055.64%
Interest Expense	$3.555M	-$41.14M	$1.860M
YoY Change	91.13%
% of Operating Profit
Other Income/Expense, Net	-$30.00K	$197.0K	-$22.12K
YoY Change	35.62%
Pretax Income	-$18.75M	-$118.2M	-$2.621M
YoY Change	615.3%	346550.4%
Income Tax	$77.00K	$1.078M	-$184.0K
% Of Pretax Income
Net Earnings	-$18.83M	-$119.3M	-$2.437M
YoY Change	672.47%	349712.03%
Net Earnings / Revenue	-51.73%	-81.93%	-6.85%
Basic Earnings Per Share	-$0.14		-$0.02
Diluted Earnings Per Share	-$0.14	-$879.8K	-$0.02
COMMON SHARES
Basic Shares Outstanding	131.9M shares	135.6M shares	105.0M shares
Diluted Shares Outstanding	131.9M shares		105.0M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$59.98M	$68.90M	$2.173M
YoY Change	2660.21%
Cash & Equivalents	$59.98M	$68.90M	$9.928M
Short-Term Investments
Other Short-Term Assets	$6.601M	$108.0M	$812.8K
YoY Change	712.13%
Inventory
Prepaid Expenses			$812.8K
Receivables	$26.62M	$28.61M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$96.14M	$206.2M	$2.986M
YoY Change	3119.86%	500.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.335M	$1.078M
YoY Change		24.91%
Goodwill	$91.64M	$91.64M
YoY Change
Intangibles	$81.98M	$83.65M
YoY Change		-7.57%
Long-Term Investments			$358.8M
YoY Change
Other Assets	$741.0K	$780.0K
YoY Change		31.53%
Total Long-Term Assets	$175.7M	$177.1M	$358.8M
YoY Change	-51.04%	-3.74%
TOTAL ASSETS
Total Short-Term Assets	$96.14M	$206.2M	$2.986M
Total Long-Term Assets	$175.7M	$177.1M	$358.8M
Total Assets	$271.8M	$383.3M	$361.8M
YoY Change	-24.87%	75.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.625M	$5.475M	$50.63K
YoY Change	12985.64%	100.48%
Accrued Expenses	$17.04M	$10.74M	$362.7K
YoY Change	4598.07%	47.66%
Deferred Revenue	$2.792M	$4.207M
YoY Change		677.63%
Short-Term Debt	$0.00	$0.00	$20.48K
YoY Change	-100.0%
Long-Term Debt Due	$3.074M	$4.233M
YoY Change		284.82%
Total Short-Term Liabilities	$30.16M	$70.02M	$435.3K
YoY Change	6827.38%	480.82%
LONG-TERM LIABILITIES
Long-Term Debt	$190.9M	$190.4M	$0.00
YoY Change		79.77%
Other Long-Term Liabilities	$343.0K	$324.0K	$12.77M
YoY Change	-97.31%	1605.26%
Total Long-Term Liabilities	$191.2M	$190.7M	$12.77M
YoY Change	1397.46%	80.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.16M	$70.02M	$435.3K
Total Long-Term Liabilities	$191.2M	$190.7M	$12.77M
Total Liabilities	$221.8M	$261.0M	$13.20M
YoY Change	1579.68%	121.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$150.2M	-$131.4M	-$647.9K
YoY Change	23086.12%	1576.32%
Common Stock	$257.6M	$253.8M	$5.648M
YoY Change	4461.29%	134.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$57.35M	$0.00
YoY Change
Treasury Stock Shares	9.953M shares	0.000 shares
Shareholders Equity	$50.05M	$122.4M	$97.99M
YoY Change
Total Liabilities & Shareholders Equity	$271.8M	$383.3M	$361.8M
YoY Change	-24.87%	75.54%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$18.83M	-$119.3M	-$2.437M
YoY Change	672.47%	349712.03%
Depreciation, Depletion And Amortization	$1.772M	$7.262M
YoY Change
Cash From Operating Activities	-$7.529M	-$17.51M	$893.0K
YoY Change	-943.11%
INVESTING ACTIVITIES
Capital Expenditures	$359.0K	-$645.0K	$170.0K
YoY Change	111.18%
Acquisitions	$0.00		$224.0K
YoY Change	-100.0%
Other Investing Activities	$0.00	$358.6M	-$358.8M
YoY Change	-100.0%
Cash From Investing Activities	-$359.0K	$357.9M	-$394.0K
YoY Change	-8.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$100.9M		-$351.6M
YoY Change	-128.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$102.1M	-181.0M	-$275.0K
YoY Change	37010.91%	-120792.73%
NET CHANGE
Cash From Operating Activities	-$7.529M	-17.51M	$893.0K
Cash From Investing Activities	-$359.0K	357.9M	-$394.0K
Cash From Financing Activities	-$102.1M	-181.0M	-$275.0K
Net Change In Cash	-$109.9M	159.4M	$224.0K
YoY Change	-49181.7%	106156.5%
FREE CASH FLOW
Cash From Operating Activities	-$7.529M	-$17.51M	$893.0K
Capital Expenditures	$359.0K	-$645.0K	$170.0K
Free Cash Flow	-$7.888M	-$16.87M	$723.0K
YoY Change	-1191.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001836981
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-40031
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	BigBear.ai Holdings, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-4164597
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6811 Benjamin Franklin Drive
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Columbia
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	125613424	shares
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	21046
CY2022Q1	dei	City Area Code CityAreaCode	410
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	312-0885
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	126263451	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59978000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68900000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	101021000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	43000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	43000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26624000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28605000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2934000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	628000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6601000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7028000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	96137000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	206182000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1335000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1078000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	91636000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	91636000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	81976000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	83646000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	741000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	780000	USD
CY2022Q1	us-gaap	Assets Assets	271825000	USD
CY2021Q4	us-gaap	Assets Assets	383322000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6625000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5475000	USD
CY2022Q1	us-gaap	Debt Current DebtCurrent	3074000	USD
CY2021Q4	us-gaap	Debt Current DebtCurrent	4233000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17042000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10735000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2792000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4207000	USD
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	44827000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	623000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	541000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	30156000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	70018000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	190853000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	190364000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	422000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	248000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	343000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	324000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	221774000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	260954000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	125613424	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	135566227	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135566227	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	14000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	14000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	257602000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	253744000	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	9952803	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	57350000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150215000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-131390000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	50051000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	122368000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	271825000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	383322000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36390000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35570000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	26523000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	25290000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	9867000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	10280000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22020000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10114000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2874000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	928000	USD
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1399000	USD
CY2021Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16426000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-762000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2437000	USD
CY2022Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1263000	USD
CY2021Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3555000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1860000	USD
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-30000	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18748000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2621000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	77000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-184000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-18825000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131882556	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131882556	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	100397000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2437000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	25000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	97985000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	122368000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-18825000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3858000	USD
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	57350000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	50051000	USD
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105000000	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-18825000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2437000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1442000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1772000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1921000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	523000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	143000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3858000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	25000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	174000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-202000	USD
CY2022Q1	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	-1263000	USD
CY2021Q1	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1981000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2306000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-897000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-432000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	653000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1150000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	174000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6307000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2316000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1415000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	130000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	83000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	21000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7529000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	893000	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	224000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	359000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	170000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-359000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-394000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100896000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1159000	USD
CY2021Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2021Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	275000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-102055000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-275000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-109943000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	224000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169921000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9704000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59978000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9928000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59978000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68900000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	101021000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59978000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169921000	USD
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021Q4	bbai	Holding Period Of Shares HoldingPeriodOfShares	P3M
CY2021Q4	bbai	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	101958000	USD
CY2021Q4	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	17391304	shares
CY2021Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	11.50
CY2021Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	114393000	USD
CY2021Q4	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	9802000	USD
CY2021Q4	bbai	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	501000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135566227	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	bbai	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	75000000	USD
CY2021Q4	bbai	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	105000000	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	8000000	shares
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	3347000	USD
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	4265000	USD
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2386000	USD
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2217000	USD
CY2022Q1	bbai	Pre Contract Costs PreContractCosts	868000	USD
CY2021Q4	bbai	Pre Contract Costs PreContractCosts	546000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6601000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7028000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10767000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9011000	USD
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	3833000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	842000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2442000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	882000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17042000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10735000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	203074000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	204233000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9147000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9636000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	193927000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	194597000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3074000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4233000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	190853000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	190364000	USD
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	200000000	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	44827000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.070
CY2021Q4	bbai	Share Repurchase Obligation Liability ShareRepurchaseObligationLiability	9952803	shares
CY2022Q1	bbai	Period For Reduced Price Repurchase PeriodForReducedPriceRepurchase	P3M
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	10.125
CY2021Q4	us-gaap	Escrow Deposit EscrowDeposit	101021000	USD
CY2022Q1	bbai	Share Repurchase Program Release Of Escrow ShareRepurchaseProgramReleaseOfEscrow	100896000	USD
CY2022Q1	bbai	Share Repurchase Program Reclassified To Cash And Cash Equivalent ShareRepurchaseProgramReclassifiedToCashAndCashEquivalent	125000	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1281000	USD
CY2022Q1	bbai	Derivative Liability Settlement DerivativeLiabilitySettlement	43546000	USD
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	125613424	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135566227	shares
CY2022Q1	bbai	Common Stock Voting Rights Vote For Each Share CommonStockVotingRightsVoteForEachShare	1	vote
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.00
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	482000	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	9.99
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P10Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	424017	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.00
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	12031	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	9.99
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	893986	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	8.57
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y8M12D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	526000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	928000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-762000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36390000	USD
CY2022Q1	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	12672000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3858000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25000	USD
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-18825000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2437000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131882556	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131882556	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	893986	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	8.57
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	17931304	shares
CY2022Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	11.50
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36390000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35570000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36390000	USD
CY2022Q1	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35570000	USD
CY2021Q1	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2021Q1	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.35
CY2021Q1	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	2228000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2934000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	628000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2792000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4207000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4207000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	136000000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.97
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10114000	USD
CY2022Q1	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.35
CY2022Q1	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	2105000	USD
CY2022Q1	bbai	Equity Based Compensation Excluded From Segment Adjusted Gross Margin EquityBasedCompensationExcludedFromSegmentAdjustedGrossMargin	-700000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22020000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2874000	USD
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1399000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16426000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1263000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	3555000	USD
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-30000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18748000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35570000	USD
CY2021Q1	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	12508000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	1860000	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2621000	USD
CY2022Q1	us-gaap	Assets Assets	271825000	USD
CY2021Q4	us-gaap	Assets Assets	383322000	USD

Files In Submission

Name	View Source	Status
0001628280-22-014091-index-headers.html	Edgar Link	pending
0001628280-22-014091-index.html	Edgar Link	pending
0001628280-22-014091.txt	Edgar Link	pending
0001628280-22-014091-xbrl.zip	Edgar Link	pending
bbai-20220331.htm	Edgar Link	pending
bbai-20220331.xsd	Edgar Link	pending
bbai-20220331_cal.xml	Edgar Link	unprocessable
bbai-20220331_def.xml	Edgar Link	unprocessable
bbai-20220331_htm.xml	Edgar Link	completed
bbai-20220331_lab.xml	Edgar Link	unprocessable
bbai-20220331_pre.xml	Edgar Link	unprocessable
exhibit311-ceocertificatio.htm	Edgar Link	pending
exhibit312-cfocertificatio.htm	Edgar Link	pending
exhibit321-906ceo3312022.htm	Edgar Link	pending
exhibit322-906cfo3312022.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BBAI
BigBear.ai Holdings Inc Stock $bbai

2022 Q1 Form 10-Q Financial Statement

#000162828022014091 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI BigBear.ai Holdings Inc Stock $bbai

2022 Q1 Form 10-Q Financial Statement

#000162828022014091 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI
BigBear.ai Holdings Inc Stock $bbai